Back

A public broadly neutralizing antibody class targets a membrane-proximal anchor epitope of influenza virus hemagglutinin

Guthmiller, J. J.; Han, J.; Utset, H. A.; Li, L.; Lan, L. Y.-L.; Henry, C.; Stamper, C. T.; Stovicek, O.; Gentles, L.; Dugan, H. L.; Zheng, N.-Y.; Richey, S. T.; Tepora, M. E.; Bitar, D. J.; Changrob, S.; Strohmeier, S.; Huang, M.; Garcia-Sastre, A.; Nachbagauer, R.; Palese, P.; Bloom, J. D.; Krammer, F.; Coughlan, L.; Ward, A. B.; Wilson, P. C.

2021-02-27 immunology
10.1101/2021.02.25.432905 bioRxiv
Show abstract

Broadly neutralizing antibodies against influenza virus hemagglutinin (HA) have the potential to provide universal protection against influenza virus infections. Here, we report a distinct class of broadly neutralizing antibodies targeting an epitope toward the bottom of the HA stalk domain where HA is "anchored" to the viral membrane. Antibodies targeting this membrane-proximal anchor epitope utilized a highly restricted repertoire, which encode for two conserved motifs responsible for HA binding. Anchor targeting B cells were common in the human memory B cell repertoire across subjects, indicating pre-existing immunity against this epitope. Antibodies against the anchor epitope at both the serological and monoclonal antibody levels were potently induced in humans by a chimeric HA vaccine, a potential universal influenza virus vaccine. Altogether, this study reveals an underappreciated class of broadly neutralizing antibodies against H1-expressing viruses that can be robustly recalled by a candidate universal influenza virus vaccine.

Matching journals

The top 3 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.